 | • レポートコード：QY2108PAL4029 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料はリプレチニブの世界市場の現状について調査・分析し、2027年までの市場を予測しました。リプレチニブの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（錠剤、カプセル）、用途別市場規模（消化管間質腫瘍治療、肥満細胞症）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・リプレチニブの世界市場概要 ・メーカー別の競争状況、市場シェア ・リプレチニブの種類別市場規模：錠剤、カプセル ・リプレチニブの用途別市場規模：消化管間質腫瘍治療、肥満細胞症 ・北米のリプレチニブ市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのリプレチニブ市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのリプレチニブ市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のリプレチニブ市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのリプレチニブ市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Zai Lab Pharmaceutical Co., Ltd.、MedChem Express、Deciphera、MedKoo Biosciences、TargetMol ・リプレチニブのバリューチェーン・販売チャネル分析 ・リプレチニブの世界市場動向 |
It is a tyrosine kinase switch control inhibitor that uses a unique dual mechanism of action to regulate the kinase switch and activation loop, thereby broadly inhibiting KIT and PDGFRα mutant kinases. It is a drug for the treatment of advanced gastrointestinal stromal tumors
Market Analysis and Insights: Global Ripretinib Market
The global Ripretinib market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
Global Ripretinib Scope and Segment
Ripretinib market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ripretinib market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Tablet
Capsule
Segment by Application
Gastric Stromal Tumor Treatment
Mastocytosis
By Company
Zai Lab Pharmaceutical Co., Ltd.
MedChem Express
Deciphera
MedKoo Biosciences
TargetMol
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Ripretinib Product Introduction
1.2 Market by Type
1.2.1 Global Ripretinib Market Size Growth Rate by Type
1.2.2 Tablet
1.2.3 Capsule
1.3 Market by Application
1.3.1 Global Ripretinib Market Size Growth Rate by Application
1.3.2 Gastric Stromal Tumor Treatment
1.3.3 Mastocytosis
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Ripretinib Sales Estimates and Forecasts 2016-2027
2.2 Global Ripretinib Revenue Estimates and Forecasts 2016-2027
2.3 Global Ripretinib Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Ripretinib Regions by Sales
2.4.1 Global Top Ripretinib Regions by Sales (2016-2021)
2.4.2 Global Top Ripretinib Regions by Sales (2022-2027)
2.5 Global Top Ripretinib Regions by Revenue
2.5.1 Global Top Ripretinib Regions by Revenue (2016-2021)
2.5.2 Global Top Ripretinib Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Ripretinib Sales by Manufacturers
3.1.1 Global Top Ripretinib Manufacturers by Sales (2016-2021)
3.1.2 Global Top Ripretinib Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Ripretinib Sales in 2020
3.2 Global Ripretinib Revenue by Manufacturers
3.2.1 Global Top Ripretinib Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Ripretinib Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Ripretinib Revenue in 2020
3.3 Global Ripretinib Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Ripretinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Ripretinib Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Ripretinib Sales by Type
4.1.1 Global Ripretinib Historical Sales by Type (2016-2021)
4.1.2 Global Ripretinib Forecasted Sales by Type (2022-2027)
4.1.3 Global Ripretinib Sales Market Share by Type (2016-2027)
4.2 Global Ripretinib Revenue by Type
4.2.1 Global Ripretinib Historical Revenue by Type (2016-2021)
4.2.2 Global Ripretinib Forecasted Revenue by Type (2022-2027)
4.2.3 Global Ripretinib Revenue Market Share by Type (2016-2027)
4.3 Global Ripretinib Price by Type
4.3.1 Global Ripretinib Price by Type (2016-2021)
4.3.2 Global Ripretinib Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Ripretinib Sales by Application
5.1.1 Global Ripretinib Historical Sales by Application (2016-2021)
5.1.2 Global Ripretinib Forecasted Sales by Application (2022-2027)
5.1.3 Global Ripretinib Sales Market Share by Application (2016-2027)
5.2 Global Ripretinib Revenue by Application
5.2.1 Global Ripretinib Historical Revenue by Application (2016-2021)
5.2.2 Global Ripretinib Forecasted Revenue by Application (2022-2027)
5.2.3 Global Ripretinib Revenue Market Share by Application (2016-2027)
5.3 Global Ripretinib Price by Application
5.3.1 Global Ripretinib Price by Application (2016-2021)
5.3.2 Global Ripretinib Price Forecast by Application (2022-2027)
6 North America
6.1 North America Ripretinib Market Size by Type
6.1.1 North America Ripretinib Sales by Type (2016-2027)
6.1.2 North America Ripretinib Revenue by Type (2016-2027)
6.2 North America Ripretinib Market Size by Application
6.2.1 North America Ripretinib Sales by Application (2016-2027)
6.2.2 North America Ripretinib Revenue by Application (2016-2027)
6.3 North America Ripretinib Market Size by Country
6.3.1 North America Ripretinib Sales by Country (2016-2027)
6.3.2 North America Ripretinib Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Ripretinib Market Size by Type
7.1.1 Europe Ripretinib Sales by Type (2016-2027)
7.1.2 Europe Ripretinib Revenue by Type (2016-2027)
7.2 Europe Ripretinib Market Size by Application
7.2.1 Europe Ripretinib Sales by Application (2016-2027)
7.2.2 Europe Ripretinib Revenue by Application (2016-2027)
7.3 Europe Ripretinib Market Size by Country
7.3.1 Europe Ripretinib Sales by Country (2016-2027)
7.3.2 Europe Ripretinib Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Ripretinib Market Size by Type
8.1.1 Asia Pacific Ripretinib Sales by Type (2016-2027)
8.1.2 Asia Pacific Ripretinib Revenue by Type (2016-2027)
8.2 Asia Pacific Ripretinib Market Size by Application
8.2.1 Asia Pacific Ripretinib Sales by Application (2016-2027)
8.2.2 Asia Pacific Ripretinib Revenue by Application (2016-2027)
8.3 Asia Pacific Ripretinib Market Size by Region
8.3.1 Asia Pacific Ripretinib Sales by Region (2016-2027)
8.3.2 Asia Pacific Ripretinib Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Ripretinib Market Size by Type
9.1.1 Latin America Ripretinib Sales by Type (2016-2027)
9.1.2 Latin America Ripretinib Revenue by Type (2016-2027)
9.2 Latin America Ripretinib Market Size by Application
9.2.1 Latin America Ripretinib Sales by Application (2016-2027)
9.2.2 Latin America Ripretinib Revenue by Application (2016-2027)
9.3 Latin America Ripretinib Market Size by Country
9.3.1 Latin America Ripretinib Sales by Country (2016-2027)
9.3.2 Latin America Ripretinib Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Ripretinib Market Size by Type
10.1.1 Middle East and Africa Ripretinib Sales by Type (2016-2027)
10.1.2 Middle East and Africa Ripretinib Revenue by Type (2016-2027)
10.2 Middle East and Africa Ripretinib Market Size by Application
10.2.1 Middle East and Africa Ripretinib Sales by Application (2016-2027)
10.2.2 Middle East and Africa Ripretinib Revenue by Application (2016-2027)
10.3 Middle East and Africa Ripretinib Market Size by Country
10.3.1 Middle East and Africa Ripretinib Sales by Country (2016-2027)
10.3.2 Middle East and Africa Ripretinib Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Zai Lab Pharmaceutical Co., Ltd.
11.1.1 Zai Lab Pharmaceutical Co., Ltd. Corporation Information
11.1.2 Zai Lab Pharmaceutical Co., Ltd. Overview
11.1.3 Zai Lab Pharmaceutical Co., Ltd. Ripretinib Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Zai Lab Pharmaceutical Co., Ltd. Ripretinib Product Description
11.1.5 Zai Lab Pharmaceutical Co., Ltd. Recent Developments
11.2 MedChem Express
11.2.1 MedChem Express Corporation Information
11.2.2 MedChem Express Overview
11.2.3 MedChem Express Ripretinib Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 MedChem Express Ripretinib Product Description
11.2.5 MedChem Express Recent Developments
11.3 Deciphera
11.3.1 Deciphera Corporation Information
11.3.2 Deciphera Overview
11.3.3 Deciphera Ripretinib Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Deciphera Ripretinib Product Description
11.3.5 Deciphera Recent Developments
11.4 MedKoo Biosciences
11.4.1 MedKoo Biosciences Corporation Information
11.4.2 MedKoo Biosciences Overview
11.4.3 MedKoo Biosciences Ripretinib Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 MedKoo Biosciences Ripretinib Product Description
11.4.5 MedKoo Biosciences Recent Developments
11.5 TargetMol
11.5.1 TargetMol Corporation Information
11.5.2 TargetMol Overview
11.5.3 TargetMol Ripretinib Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 TargetMol Ripretinib Product Description
11.5.5 TargetMol Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Ripretinib Value Chain Analysis
12.2 Ripretinib Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Ripretinib Production Mode & Process
12.4 Ripretinib Sales and Marketing
12.4.1 Ripretinib Sales Channels
12.4.2 Ripretinib Distributors
12.5 Ripretinib Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Ripretinib Industry Trends
13.2 Ripretinib Market Drivers
13.3 Ripretinib Market Challenges
13.4 Ripretinib Market Restraints
14 Key Findings in The Global Ripretinib Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Ripretinib Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Tablet
Table 3. Major Manufacturers of Capsule
Table 4. Global Ripretinib Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Ripretinib Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Ripretinib Sales by Region (2016-2021) & (K Units)
Table 7. Global Ripretinib Sales Market Share by Region (2016-2021)
Table 8. Global Ripretinib Sales by Region (2022-2027) & (K Units)
Table 9. Global Ripretinib Sales Market Share by Region (2022-2027)
Table 10. Global Ripretinib Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Ripretinib Revenue Market Share by Region (2016-2021)
Table 12. Global Ripretinib Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Ripretinib Revenue Market Share by Region (2022-2027)
Table 14. Global Ripretinib Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Ripretinib Sales Share by Manufacturers (2016-2021)
Table 16. Global Ripretinib Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Ripretinib Revenue Share by Manufacturers (2016-2021)
Table 18. Ripretinib Price by Manufacturers 2016-2021 (US$/Unit)
Table 19. Global Ripretinib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Ripretinib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ripretinib as of 2020)
Table 21. Ripretinib Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Ripretinib Product Offered
Table 23. Date of Manufacturers Enter into Ripretinib Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Ripretinib Sales by Type (2016-2021) & (K Units)
Table 26. Global Ripretinib Sales by Type (2022-2027) & (K Units)
Table 27. Global Ripretinib Sales Share by Type (2016-2021)
Table 28. Global Ripretinib Sales Share by Type (2022-2027)
Table 29. Global Ripretinib Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Ripretinib Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Ripretinib Revenue Share by Type (2016-2021)
Table 32. Global Ripretinib Revenue Share by Type (2022-2027)
Table 33. Ripretinib Price by Type (2016-2021) & (US$/Unit)
Table 34. Global Ripretinib Price Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Ripretinib Sales by Application (2016-2021) & (K Units)
Table 36. Global Ripretinib Sales by Application (2022-2027) & (K Units)
Table 37. Global Ripretinib Sales Share by Application (2016-2021)
Table 38. Global Ripretinib Sales Share by Application (2022-2027)
Table 39. Global Ripretinib Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Ripretinib Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Ripretinib Revenue Share by Application (2016-2021)
Table 42. Global Ripretinib Revenue Share by Application (2022-2027)
Table 43. Ripretinib Price by Application (2016-2021) & (US$/Unit)
Table 44. Global Ripretinib Price Forecast by Application (2022-2027) & (US$/Unit)
Table 45. North America Ripretinib Sales by Type (2016-2021) & (K Units)
Table 46. North America Ripretinib Sales by Type (2022-2027) & (K Units)
Table 47. North America Ripretinib Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Ripretinib Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Ripretinib Sales by Application (2016-2021) & (K Units)
Table 50. North America Ripretinib Sales by Application (2022-2027) & (K Units)
Table 51. North America Ripretinib Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Ripretinib Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Ripretinib Sales by Country (2016-2021) & (K Units)
Table 54. North America Ripretinib Sales by Country (2022-2027) & (K Units)
Table 55. North America Ripretinib Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Ripretinib Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Ripretinib Sales by Type (2016-2021) & (K Units)
Table 58. Europe Ripretinib Sales by Type (2022-2027) & (K Units)
Table 59. Europe Ripretinib Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Ripretinib Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Ripretinib Sales by Application (2016-2021) & (K Units)
Table 62. Europe Ripretinib Sales by Application (2022-2027) & (K Units)
Table 63. Europe Ripretinib Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Ripretinib Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Ripretinib Sales by Country (2016-2021) & (K Units)
Table 66. Europe Ripretinib Sales by Country (2022-2027) & (K Units)
Table 67. Europe Ripretinib Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Ripretinib Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Ripretinib Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Ripretinib Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Ripretinib Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Ripretinib Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Ripretinib Sales by Application (2016-2021) & (K Units)
Table 74. Asia Pacific Ripretinib Sales by Application (2022-2027) & (K Units)
Table 75. Asia Pacific Ripretinib Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Ripretinib Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Ripretinib Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Ripretinib Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Ripretinib Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Ripretinib Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Ripretinib Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Ripretinib Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Ripretinib Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Ripretinib Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Ripretinib Sales by Application (2016-2021) & (K Units)
Table 86. Latin America Ripretinib Sales by Application (2022-2027) & (K Units)
Table 87. Latin America Ripretinib Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Ripretinib Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Ripretinib Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Ripretinib Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Ripretinib Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Ripretinib Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Ripretinib Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Ripretinib Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Ripretinib Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Ripretinib Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Ripretinib Sales by Application (2016-2021) & (K Units)
Table 98. Middle East and Africa Ripretinib Sales by Application (2022-2027) & (K Units)
Table 99. Middle East and Africa Ripretinib Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Ripretinib Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Ripretinib Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Ripretinib Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Ripretinib Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Ripretinib Revenue by Country (2022-2027) & (US$ Million)
Table 105. Zai Lab Pharmaceutical Co., Ltd. Corporation Information
Table 106. Zai Lab Pharmaceutical Co., Ltd. Description and Major Businesses
Table 107. Zai Lab Pharmaceutical Co., Ltd. Ripretinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. Zai Lab Pharmaceutical Co., Ltd. Ripretinib Product
Table 109. Zai Lab Pharmaceutical Co., Ltd. Recent Developments
Table 110. MedChem Express Corporation Information
Table 111. MedChem Express Description and Major Businesses
Table 112. MedChem Express Ripretinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. MedChem Express Ripretinib Product
Table 114. MedChem Express Recent Developments
Table 115. Deciphera Corporation Information
Table 116. Deciphera Description and Major Businesses
Table 117. Deciphera Ripretinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Deciphera Ripretinib Product
Table 119. Deciphera Recent Developments
Table 120. MedKoo Biosciences Corporation Information
Table 121. MedKoo Biosciences Description and Major Businesses
Table 122. MedKoo Biosciences Ripretinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. MedKoo Biosciences Ripretinib Product
Table 124. MedKoo Biosciences Recent Developments
Table 125. TargetMol Corporation Information
Table 126. TargetMol Description and Major Businesses
Table 127. TargetMol Ripretinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. TargetMol Ripretinib Product
Table 129. TargetMol Recent Developments
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Ripretinib Distributors List
Table 133. Ripretinib Customers List
Table 134. Ripretinib Market Trends
Table 135. Ripretinib Market Drivers
Table 136. Ripretinib Market Challenges
Table 137. Ripretinib Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Ripretinib Product Picture
Figure 2. Global Ripretinib Market Share by Type in 2020 & 2027
Figure 3. Tablet Product Picture
Figure 4. Capsule Product Picture
Figure 5. Global Ripretinib Market Share by Application in 2020 & 2027
Figure 6. Gastric Stromal Tumor Treatment
Figure 7. Mastocytosis
Figure 8. Ripretinib Report Years Considered
Figure 9. Global Ripretinib Sales 2016-2027 (K Units)
Figure 10. Global Ripretinib Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Ripretinib Revenue 2016-2027 (US$ Million)
Figure 12. Global Ripretinib Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 13. Global Ripretinib Sales Market Share by Region (2016-2021)
Figure 14. Global Ripretinib Sales Market Share by Region (2022-2027)
Figure 15. North America Ripretinib Sales YoY (2016-2027) & (K Units)
Figure 16. North America Ripretinib Revenue YoY (2016-2027) & (US$ Million)
Figure 17. Europe Ripretinib Sales YoY (2016-2027) & (K Units)
Figure 18. Europe Ripretinib Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Asia-Pacific Ripretinib Sales YoY (2016-2027) & (K Units)
Figure 20. Asia-Pacific Ripretinib Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Latin America Ripretinib Sales YoY (2016-2027) & (K Units)
Figure 22. Latin America Ripretinib Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Middle East & Africa Ripretinib Sales YoY (2016-2027) & (K Units)
Figure 24. Middle East & Africa Ripretinib Revenue YoY (2016-2027) & (US$ Million)
Figure 25. The Top 10 and Top 5 Players Market Share by Ripretinib Sales in 2020
Figure 26. The Top 10 and Top 5 Players Market Share by Ripretinib Revenue in 2020
Figure 27. Ripretinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 28. Global Ripretinib Sales Market Share by Type (2016-2027)
Figure 29. Global Ripretinib Revenue Market Share by Type (2016-2027)
Figure 30. Global Ripretinib Sales Market Share by Application (2016-2027)
Figure 31. Global Ripretinib Revenue Market Share by Application (2016-2027)
Figure 32. North America Ripretinib Sales Market Share by Type (2016-2027)
Figure 33. North America Ripretinib Revenue Market Share by Type (2016-2027)
Figure 34. North America Ripretinib Sales Market Share by Application (2016-2027)
Figure 35. North America Ripretinib Revenue Market Share by Application (2016-2027)
Figure 36. North America Ripretinib Sales Share by Country (2016-2027)
Figure 37. North America Ripretinib Revenue Share by Country (2016-2027)
Figure 38. United States Ripretinib Revenue (2016-2027) & (US$ Million)
Figure 39. Canada Ripretinib Revenue (2016-2027) & (US$ Million)
Figure 40. Europe Ripretinib Sales Market Share by Type (2016-2027)
Figure 41. Europe Ripretinib Revenue Market Share by Type (2016-2027)
Figure 42. Europe Ripretinib Sales Market Share by Application (2016-2027)
Figure 43. Europe Ripretinib Revenue Market Share by Application (2016-2027)
Figure 44. Europe Ripretinib Sales Share by Country (2016-2027)
Figure 45. Europe Ripretinib Revenue Share by Country (2016-2027)
Figure 46. Germany Ripretinib Revenue (2016-2027) & (US$ Million)
Figure 47. France Ripretinib Revenue (2016-2027) & (US$ Million)
Figure 48. U.K. Ripretinib Revenue (2016-2027) & (US$ Million)
Figure 49. Italy Ripretinib Revenue (2016-2027) & (US$ Million)
Figure 50. Russia Ripretinib Revenue (2016-2027) & (US$ Million)
Figure 51. Asia Pacific Ripretinib Sales Market Share by Type (2016-2027)
Figure 52. Asia Pacific Ripretinib Revenue Market Share by Type (2016-2027)
Figure 53. Asia Pacific Ripretinib Sales Market Share by Application (2016-2027)
Figure 54. Asia Pacific Ripretinib Revenue Market Share by Application (2016-2027)
Figure 55. Asia Pacific Ripretinib Sales Share by Region (2016-2027)
Figure 56. Asia Pacific Ripretinib Revenue Share by Region (2016-2027)
Figure 57. China Ripretinib Revenue (2016-2027) & (US$ Million)
Figure 58. Japan Ripretinib Revenue (2016-2027) & (US$ Million)
Figure 59. South Korea Ripretinib Revenue (2016-2027) & (US$ Million)
Figure 60. India Ripretinib Revenue (2016-2027) & (US$ Million)
Figure 61. Australia Ripretinib Revenue (2016-2027) & (US$ Million)
Figure 62. China Taiwan Ripretinib Revenue (2016-2027) & (US$ Million)
Figure 63. Indonesia Ripretinib Revenue (2016-2027) & (US$ Million)
Figure 64. Thailand Ripretinib Revenue (2016-2027) & (US$ Million)
Figure 65. Malaysia Ripretinib Revenue (2016-2027) & (US$ Million)
Figure 66. Latin America Ripretinib Sales Market Share by Type (2016-2027)
Figure 67. Latin America Ripretinib Revenue Market Share by Type (2016-2027)
Figure 68. Latin America Ripretinib Sales Market Share by Application (2016-2027)
Figure 69. Latin America Ripretinib Revenue Market Share by Application (2016-2027)
Figure 70. Latin America Ripretinib Sales Share by Country (2016-2027)
Figure 71. Latin America Ripretinib Revenue Share by Country (2016-2027)
Figure 72. Mexico Ripretinib Revenue (2016-2027) & (US$ Million)
Figure 73. Brazil Ripretinib Revenue (2016-2027) & (US$ Million)
Figure 74. Argentina Ripretinib Revenue (2016-2027) & (US$ Million)
Figure 75. Colombia Ripretinib Revenue (2016-2027) & (US$ Million)
Figure 76. Middle East and Africa Ripretinib Sales Market Share by Type (2016-2027)
Figure 77. Middle East and Africa Ripretinib Revenue Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Ripretinib Sales Market Share by Application (2016-2027)
Figure 79. Middle East and Africa Ripretinib Revenue Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Ripretinib Sales Share by Country (2016-2027)
Figure 81. Middle East and Africa Ripretinib Revenue Share by Country (2016-2027)
Figure 82. Turkey Ripretinib Revenue (2016-2027) & (US$ Million)
Figure 83. Saudi Arabia Ripretinib Revenue (2016-2027) & (US$ Million)
Figure 84. UAE Ripretinib Revenue (2016-2027) & (US$ Million)
Figure 85. Ripretinib Value Chain
Figure 86. Ripretinib Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
世界の錠剤＆カプセル検査装置市場インサイト・予測（～2027年） Market Analysis and Insights: Global Tablet and Capsule Inspection Equipment Market The global Tablet and Capsule Inspection Equipment market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Tablet an…- 世界の錠剤＆カプセル検査装置市場インサイト・予測（～2027年） Market Analysis and Insights: Global Tablet and Capsule Inspection Equipment Market The global Tablet and Capsule Inspection Equipment market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Tablet an…
- 消化管間質腫瘍（GIST）治療薬の世界市場 2020年 Market Overview The global Gastrointestinal Stromal Tumor (GIST) Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ga…
- 全身性肥満細胞症治療の世界市場 2020年 Market Overview The global Systemic Mastocytosis Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Systemic Mast…
- 世界の腫瘍局在化システム市場インサイト・予測（～2027年） Market Analysis and Insights: Global Tumor Localization System Market The global Tumor Localization System market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Tumor Localization System Scope and S…